drugset / Trial / NCT06497647
New Treatment for Nocturnal Enuresis in Children
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of the study is to evaluate the role of sulbutiamine in treatment of monosymptomatic nocturnal enuresis in children by using it alone or as a combination therapy with tricyclic antidepressants (imipramine+sulbutiamine).
Timeline
- Start
- 2024-03-01
- Primary completion
- 2024-09
- Completion
- 2024-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Imipramine | Small molecule | 25 mg | Oral |
| Comparator | Sulbutiamine | Small molecule | 100 mg | Oral |